Ilya M. Rachman
CEO and Chairman at Immix Biopharma · 3 reported transactions in 1 company · latest trade Dec 10, 2025
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +176.2%, S&P 500 +14.3% over the same days.
Their trades
Bought | Dec 10, 2025 | Dec 10, 2025 close $6.73 → Oct 28, 2026 close $8.13. S&P 500 +12.3% over the same days. | ||
Bought | Sep 17, 2025 | Sep 17, 2025 close $1.96 → Oct 28, 2026 close $8.13. S&P 500 +17.2% over the same days. | ||
Bought | Jun 18, 2025 | Jun 18, 2025 close $2.39 → Oct 28, 2026 close $8.13. S&P 500 +29.3% over the same days. |
BoughtImmix Biopharma
$5K
Dec 10, 2025 close $6.73 → Oct 28, 2026 close $8.13. S&P 500 +12.3% over the same days.
BoughtImmix Biopharma
$5K
Sep 17, 2025 close $1.96 → Oct 28, 2026 close $8.13. S&P 500 +17.2% over the same days.
BoughtImmix Biopharma
$5K
Jun 18, 2025 close $2.39 → Oct 28, 2026 close $8.13. S&P 500 +29.3% over the same days.